Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Tariff Resilience Score: 4/10 (As of Jul. 11, 2026)


FRA:GU5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd FRA:GU5
68 GF Score
Price €1.66
GF Value €2.39
Valuation Significantly Undervalued
! 6 Warning Signs
View Full Analysis

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Tariff Resilience Score?

Guangzhou Baiyunshan Pharmaceutical Holdings Co FRA:GU5 -0.60% 68 Tariff Resilience Score is 4 as of Jul. 11, 2026. GuruFocus rates FRA:GU5 with a GF Score™ of 68/100 and a GF Value™ of €2.39 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 119 Medical Distribution companies, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks better than 87.39% on this metric.

Guangzhou Baiyunshan Pharmaceutical Holdings Co has the Tariff Resilience Score of 4, which implies that the company might have Average Resilient.

Guangzhou Baiyunshan Pharmaceutical Holdings Co has Guangzhou Baiyunshan faces tariff exposure on raw materials and finished goods in the pharmaceutical sector. While some exemptions exist, the company is vulnerable to changes in trade policies affecting its supply chain and export markets.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Guangzhou Baiyunshan Pharmaceutical Holdings Co might have Average Resilient.

Guangzhou Baiyunshan Pharmaceutical Holdings Co  (FRA:GU5) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Guangzhou Baiyunshan Pharmaceutical Holdings Co Tariff Resilience Score Related Terms

FRA:GU5 vs MCK, CAH, COR: Tariff Resilience Score Comparison

For the Medical Distribution subindustry, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Tariff Resilience Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Guangzhou Baiyunshan Pharmaceutical Holdings Co's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Guangzhou Baiyunshan Pharmaceutical Holdings Co's Tariff Resilience Score falls into.


FRA:GU5
68GF Score
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd FRA:GU5
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 4 mean?
Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) has a Tariff Resilience Score of 4 as of Jul. 11, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #15 out of 119 companies in the Medical Distribution industry, placing it in the top 12.6%.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co's Tariff Resilience Score too high?
Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Tariff Resilience Score is 4. Based on the distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #15 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Guangzhou Baiyunshan Pharmaceutical Holdings Co has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Baiyunshan Pharmaceutical Holdings Co's Tariff Resilience Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Guangzhou Baiyunshan Pharmaceutical Holdings Co ranks #15 out of 119 companies for Tariff Resilience Score. This places Guangzhou Baiyunshan Pharmaceutical Holdings Co in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Distribution company?
A good Tariff Resilience Score depends on the Medical Distribution industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Guangzhou Baiyunshan Pharmaceutical Holdings Co's current Tariff Resilience Score is 4. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Baiyunshan Pharmaceutical Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) is currently considered Significantly Undervalued. The stock's GF Value™ is €2.39, compared to a current price of €1.66 — trading 30.5% below its estimated fair value. The current Tariff Resilience Score is 4. Guangzhou Baiyunshan Pharmaceutical Holdings Co's overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5), the current Tariff Resilience Score is 4 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Baiyunshan Pharmaceutical Holdings Co (FRA:GU5) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Baiyunshan Pharmaceutical Holdings Co stock appears to be undervalued. The current stock price of €1.66 is trading 30.5% below its estimated GF Value™ of €2.39. GuruFocus considers Guangzhou Baiyunshan Pharmaceutical Holdings Co to be Significantly Undervalued.

Key valuation signals for FRA:GU5:

  • Tariff Resilience Score: 4
  • GF Value™: €2.39 vs. price of €1.66 (30.5% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the FRA:GU5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Business Description

Other Exchanges 00874:Hong Kong600332:China
Address 45 Sha Mian North Street, Liwan District, Guangdong Province, Guangzhou, CHN, 510130
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd is engaged in the pharmaceutical and healthcare industry, focusing on the development of a full industrial chain covering research, manufacturing, and distribution. The group operates through five reportable segments. The Modern Chinese Medicine segment involves the R&D, manufacturing, and sale of proprietary Chinese and natural medicines. The Chemical Pharmaceutical Technology segment focuses on chemical drugs, APIs, and intermediates. The Natural Beverages segment produces and sells health-oriented beverage products. The Pharmaceutical Commerce segment is engaged in the wholesale, retail, and import/export of medicines and medical devices. The Other Segments include biotechnology innovation, consumer health, and medical services.
68GF Score

Get the complete analysis for FRA:GU5

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.66
Price
€2.39
GF Value